THE EFFECT OF DIFFERENT ROUTES OF ADMINISTRATION ON THE METABOLISM OF MORPHINE - THE DISPOSITION OF MORPHINE AND ITS METABOLITES AFTER TOPICAL APPLICATION

被引:11
作者
MATSUZAWA, T [1 ]
WADA, Y [1 ]
SHIMOYAMA, M [1 ]
NAKAJIMA, K [1 ]
SEKI, T [1 ]
SUGIBAYASHI, K [1 ]
MORIMOTO, Y [1 ]
机构
[1] JOSAI UNIV,FAC PHARMACEUT SCI,SAKADO,SAITAMA 35002,JAPAN
关键词
TOPICAL APPLICATION; MORPHINE; MORPHINE-3-GLUCURONIDE; MORPHINE-6-GLUCURONIDE; RABBIT;
D O I
10.1002/bdd.2510150805
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The disposition of morphine (MOR) and its metabolites in the rabbit was measured after topical administration of its hydrochloride salt (MOR.HCl), and their time course was compared with those after intravenous and oral administration. The area under the plasma concentration-time curve (AUC) ratio of metabolites/MOR after the topical application of MOR.HCl was similar to that after intravenous injection, but differed from that after oral administration. Pharmacokinetic parameters of the disposition of MOR and its metabolites were obtained by a general curve fitting of the time course of plasma concentrations of these compounds after intravenous injection of MOR.HCl and its metabolites, respectively. On the other hand, the time courses of plasma concentrations of the metabolites after intravenous, oral, and topical administration of MOR.HCl were simulated using a simple compartment model without consideration of enterohepatic circulation and the pharmacokinetic parameters obtained as above. The resulting curves of the metabolites agreed well with the observed values except for those after oral administration. These results suggest that no first-pass metabolism of MOR.HCl occurs after percutaneous administration, and that topical administration of this salt is more advantageous than oral administration in terms of bioavailability.
引用
收藏
页码:665 / 678
页数:14
相关论文
共 21 条
[1]   PHARMACOKINETICS AND PHARMACODYNAMICS OF MORPHINE-3-GLUCURONIDE IN RATS AND ITS INFLUENCE ON THE ANTINOCICEPTIVE EFFECT OF MORPHINE [J].
EKBLOM, M ;
GARDMARK, M ;
HAMMARLUNDUDENAES, M .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1993, 14 (01) :1-11
[2]  
HANANO M, 1970, YAKKYOKU, V21, P1019
[3]   AN IMPROVED METHOD FOR THE SIMULTANEOUS DETERMINATION OF MORPHINE AND ITS PRINCIPAL GLUCURONIDE METABOLITES [J].
JOEL, SP ;
OSBORNE, RJ ;
SLEVIN, ML .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 430 (02) :394-399
[4]  
KLAASSEN CD, 1984, PHARMACOL REV, V36, P1
[5]   A NEW ENHANCER-COENHANCER SYSTEM TO INCREASE SKIN PERMEATION OF MORPHINE HYDROCHLORIDE INVITRO [J].
MORIMOTO, Y ;
SUGIBAYASHI, K ;
KOBAYASHI, D ;
SHOJI, H ;
YAMAZAKI, J ;
KIMURA, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 91 (01) :9-14
[6]  
OSBORNE R, 1988, LANCET, V1, P828
[7]   MORPHINE AND METABOLITE BEHAVIOR AFTER DIFFERENT ROUTES OF MORPHINE ADMINISTRATION - DEMONSTRATION OF THE IMPORTANCE OF THE ACTIVE METABOLITE MORPHINE-6-GLUCURONIDE [J].
OSBORNE, R ;
JOEL, S ;
TREW, D ;
SLEVIN, M .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (01) :12-19
[8]  
PAUL D, 1989, J PHARMACOL EXP THER, V251, P477
[9]   THE METABOLITE MORPHINE-6-GLUCURONIDE CONTRIBUTES TO THE ANALGESIA PRODUCED BY MORPHINE INFUSION IN PATIENTS WITH PAIN AND NORMAL RENAL-FUNCTION [J].
PORTENOY, RK ;
THALER, HT ;
INTURRISI, CE ;
FRIEDLANDERKLAR, H ;
FOLEY, KM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (04) :422-431
[10]   CSF CONCENTRATIONS OF MORPHINE-6-GLUCURONIDE AFTER ORAL-ADMINISTRATION OF MORPHINE [J].
POULAIN, P ;
RIBON, AM ;
HANKS, GW ;
HOSKIN, PJ ;
AHERNE, GW ;
CHAPMAN, DJ .
PAIN, 1990, 41 (01) :115-116